S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
NFLX   360.09 (-2.34%)
BAC   31.08 (-5.04%)
GILD   70.10 (-3.84%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 OrthopediatricsIntersect ENTLeMaitre VascularAntares PharmaAnika Therapeutics
SymbolNASDAQ:KIDSNASDAQ:XENTNASDAQ:LMATNASDAQ:ATRSNASDAQ:ANIK
Price Information
Current Price$47.92$23.60$29.78$3.33$42.60
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$50.25$25.82$39.33$4.21$53.75
% Upside from Price Target4.86% upside9.41% upside32.08% upside26.53% upside26.17% upside
Trade Information
Market Cap$812.89 million$843.34 million$595.30 million$558.25 million$610.02 million
Beta0.30.911.230.920.98
Average Volume108,110795,432135,1801,394,543195,632
Sales & Book Value
Annual Revenue$57.56 million$108.47 million$117.23 million$63.55 million$114.51 million
Price / Sales13.926.865.088.555.31
CashflowN/AN/A$1.07 per shareN/A$2.29 per share
Price / CashN/AN/A27.85N/A18.60
Book Value$6.38 per share$3.96 per share$7.41 per share$0.25 per share$20.21 per share
Price / Book7.515.964.0213.322.11
Profitability
Net Income$-12,020,000.00$-22,920,000.00$17.93 million$-6,510,000.00$27.19 million
EPS($0.96)($0.76)$0.88($0.04)$2.05
Trailing P/E RatioN/AN/A33.84333.3322.42
Forward P/E RatioN/AN/A27.5737.0028.03
P/E GrowthN/AN/A$3.90N/A$2.71
Net Margins-15.80%-36.37%15.30%-0.56%23.73%
Return on Equity (ROE)-12.12%-34.19%12.85%-1.40%10.81%
Return on Assets (ROA)-7.70%-29.44%10.58%-0.56%9.47%
Dividend
Annual PayoutN/AN/A$0.34N/AN/A
Dividend YieldN/AN/A1.14%N/AN/A
Three-Year Dividend GrowthN/AN/A19.98%N/AN/A
Payout RatioN/AN/A38.64%N/AN/A
Years of Consecutive Dividend GrowthN/AN/A4 YearsN/AN/A
Debt
Debt-to-Equity Ratio0.24%N/AN/A1.00%0.07%
Current Ratio2.35%6.37%4.42%2.95%14.48%
Quick Ratio1.61%5.49%2.52%2.46%13.13%
Ownership Information
Institutional Ownership Percentage57.64%99.14%86.60%43.01%95.79%
Insider Ownership Percentage40.70%6.50%19.60%5.49%3.67%
Miscellaneous
Employees80393N/A165133
Shares Outstanding16.72 million31.52 million19.99 million163.23 million14.27 million
Next Earnings Date3/4/2020 (Confirmed)5/4/2020 (Estimated)5/6/2020 (Estimated)3/3/2020 (Confirmed)5/7/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel